Dramatic response to Evinacumab in a North Indian girl with homozygous familial hypercholesterolemia
Evinacumab offers a promising option for managing high-risk and difficult-to-treat HoFH patients. This is the first Indian child receiving Evinacumab for HoFH.
Authors
- Arun George (ORCID: https://orcid.org/0000-0002-1690-0359)
- Sayan Banerjee (ORCID: https://orcid.org/0000-0003-4191-3765)
- Shilpa Arora (ORCID: https://orcid.org/0000-0003-4744-1615)
- Devi Dayal (ORCID: https://orcid.org/0000-0002-3279-6002)
- Anju Bala (ORCID: https://orcid.org/0009-0002-2844-022X)
- Manoj Kumar Rohit
- Shyam Kumar Singh Thingnam
Institutions
- Post Graduate Institute of Medical Education and Research (IN)
Publication Details
- Journal
- Journal of Pediatric Endocrinology and Metabolism
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1515/jpem-2024-0506
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.57